As a founding partner of Gavi, the Gates Foundation has helped elevate immunisation on the global agenda and has been one of the Vaccine Alliance’s most influential supporters since its inception. Its initial US$ 750 million commitment in 2000 was catalytic in establishing Gavi and mobilising support from other donors. The foundation has also played a pivotal role in the Gavi Matching Fund, an innovative financing mechanism that matches private sector contributions; and has helped unlock additional resources, partnerships and expertise for immunisation programmes worldwide.
Since then, the foundation has supported key Gavi initiatives, including a US$ 50 million contribution to launch the first Advance Market Commitment (AMC) for pneumococcal vaccines in 2007, more than US$ 1.3 billion for Gavi’s 2011–2015 strategic period, US$ 241 million for polio eradication efforts from 2015–2018, US$ 1.55 billion for Gavi’s 2016–2020 strategic period, and over US$ 1.8 billion for Gavi’s 2021–2025 period, alongside US$ 234 million for the Gavi COVAX AMC.
Most recently, at the Global Summit: Health & Prosperity through Immunisation in Brussels in June 2025, the Gates Foundation pledged a further US$ 1.6 billion to support Gavi 6.0 (2026–2030), reaffirming its long-standing commitment to protecting children through immunisation and strengthening global health security.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: